# US 2023/0410940 A1 · Engineered bacterial cells and methods of producing the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0410940 A1
- Document ID: US20230410940A1
- Status: Published application
- Kind: A1
- Application number: 18/115,412
- Filed: 2023-02-28
- Published: 2023-12-21
- Earliest claimed: 2022-03-01
- Assignees: Uchicago Argonne, LLC
- Applicants: Uchicago Argonne, LLC
- Inventors: Michael Fonstein; Paul D. Hanke; Bruce Parrello; Rick Stevens; Thomas S. Brettin; Christopher S. Henry
- Web page: https://patentgrep.com/patent/US20230410940A1

## CPC

- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- C12N 1/20: Bacteria; Culture media therefor
- C12R 2001/19: Escherichia coli
- G16B 40/20: Supervised data analysis
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present disclosure provides novel engineered target-biomolecule-producing bacterial strains and methods of producing the same. To engineer bacterial strains capable of producing substantial levels of a target biomolecule, the methods may implement the use of metabolic modeling and machine learning methods. The methods and bacterial strains produced by the methods may be implemented in further optimizing a biosynthetic pathway, e.g., to improve the production of a target biomolecule of interest, e.g., an amino acid, such as threonine.

## Claims

### Claim 1

A method of engineering a target-biomolecule-producing bacterial cell, the method comprising:
(i) identifying a set of optimized parameters predicted to result in increased production of the target biomolecule by the bacterial cell;
(ii) constructing a plurality of bacterial strains, each bacterial strain comprising one or more of the optimized parameters of the set of optimized parameters identified in (i);
(iii) collecting target biomolecule production data from the strains constructed in (ii);
(iv) performing a computational analysis of the data collected in (iii) in order to obtain a further optimized set of parameters that predict increased production of the target biomolecule.
(v) repeating steps (ii), (iii), and (iv); and
(vi) constructing one or more final bacterial strains, each bacterial strain comprising one or more of the optimized parameters of the set of optimized parameters identified in (i) or (iv).

### Claim 2 (depends on 1)

The method of claim 1, wherein the bacterial cell comprises a modified operon comprising a gene sequence encoding the target biomolecule.

### Claim 3 (depends on 2)

The method of claim 2, wherein the modified operon is operably linked to a non-native promoter.

### Claim 4 (depends on 1)

The method of claim 1, wherein the parameters are selected from the group consisting of host strain, inactivated genes, and overexpressed genes.

### Claim 5 (depends on 1)

The method of claim 1, wherein the step of repeating is performed at least twice.

### Claim 6 (depends on 1)

The method of claim 1, wherein the computational analysis comprises machine learning (ML).

### Claim 7 (depends on 6)

The method of claim 6, wherein the computational analysis further comprises metabolic modeling (MM).

### Claim 8 (depends on 1)

The method of claim 1, wherein the parameters further comprise:
(i) presence of endogenous operon comprising the gene sequence encoding the target biomolecule;
(ii) chromosomal or plasmid localization of the modified operon;
(iii) induction of the modified operon by Isopropyl β-D-1-thiogalactopyranoside (IPTG);
(iv) growth time post-induction; and
(v) culture medium type.

### Claim 9 (depends on 1)

The method of claim 1, wherein the step of collecting further comprises collecting one or more of bacterial cell growth rate data, sugar conversion data, and RNA-Seq data.

### Claim 10 (depends on 1)

The method of claim 1, wherein the bacterial cell is a bacterial cell of the strain ATCC 21277.

### Claim 11

An engineered bacterial cell capable of producing threonine, wherein the engineered bacterial cell comprises a chromosome comprising a metL deletion.

### Claim 12 (depends on 11)

The engineered bacterial cell of claim 11, wherein the engineered bacterial cell is an E. coli cell.

### Claim 13 (depends on 12)

The engineered bacterial cell of claim 12, wherein the E. coli cell is an E. coli cell of the strain ATCC 21277.

### Claim 14 (depends on 11)

The engineered bacterial cell of claim 11, wherein the engineered bacterial cell comprises an attenuated metL gene.

### Claim 15 (depends on 11)

The engineered bacterial cell of claim 11, wherein the engineered bacterial cell comprises a chromosome comprising a deletion of one or more of tdh, dapA, and dhaM.

### Claim 16 (depends on 15)

The engineered bacterial cell of claim 15, wherein the engineered bacterial cell comprises a plasmid comprising a nucleotide sequence encoding a ppc gene.

### Claim 17 (depends on 15)

The engineered bacterial cell of claim 15, wherein the engineered bacterial cell comprises a plasmid comprising a nucleotide sequence encoding an aspC gene.

### Claim 18 (depends on 15)

The engineered bacterial cell of claim 15, wherein the engineered bacterial cell comprises a plasmid comprising a nucleotide sequence encoding a pntAB gene.

### Claim 19 (depends on 15)

The engineered bacterial cell of claim 15, wherein the engineered bacterial cell comprises one or more plasmids, each plasmid comprising one or more nucleotide sequences encoding one or more of a ppc gene, an aspC gene, and a pntAB gene.

### Claim 20 (depends on 15)

The engineered bacterial cell of claim 15, wherein the engineered bacterial cell comprises a chromosome comprising at least two copies of one or more genes selected from ppc, aspC, and pntAB, thereby promoting overexpression of the one or more genes.

### Claim 21 (depends on 15)

The engineered bacterial cell of claim 15, wherein the engineered bacterial cell comprises a chromosome comprising one or more of: (i) a ppc gene operably linked to a non-native promoter; (ii) an aspC gene operably linked to a non-native promoter; and (iii) a pntAB gene operably linked to a non-native promoter.

### Claim 22 (depends on 21)

The engineered bacterial cell of claim 21, wherein the non-native promoter is a tac promoter.
